We recently published 12 Stocks Jim Cramer Recently Discussed As He Commented On A “Sea Of Green”. Eli Lilly and Company ...

Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.

President Trump published letters to 17 major pharma companies reiterating his requirements for them to fulfill his MFN order ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

President Trump on Thursday sent letters to 17 of the world’s largest drug companies, telling them to take more steps to ...

In letters to the companies released on Thursday, Trump said he expected them to deliver on a series of measures to lower prices by September 29. “If you refuse to step up, we will deploy every tool ...

President Trump on Thursday said he demanded commitments from 17 big drugmakers to lower their U.S. prices by committing to a ...

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

Eli Lilly drug Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the ...

Novo Nordisk (NVO) downgraded to Hold by HSBC amid growth concerns, GLP-1 market challenges, and revised 2025-2026 earnings ...

Ozempic-famed Novo Nordisk took over a $70 billion wipeout off its market value this week. Is this the beginning of a trend, ...